Detailed
Agenda - 14th International Symposium on
NeuroVirology
Return
to the Program page
7:00 am
|
Symposium
Registration and Continental Breakfast
(Vanity Fair Foyer and Pall Mall, Second
Level)
|
Welcome and
Opening Remarks (Vanity Fair Ballroom,
Second Level)
|
8:00 am
|
OHTN:
Sean Rourke (Scientific and
Executive Director, OHTN)
ISNV:
Lynn Pulliam (Co-Chair, ISNV Meetings
Committee)
Igor
Koralnik (President, International
Society for NeuroVirology)
|
Joint session 1:
How aging and comorbidities affect the
brain (Vanity Fair Ballroom, Second
Level)
For people with
HIV, how do aging and comorbidities
affect their brains? What are the
neuro-mechanisms? Are there strategies
to protect the brain?
Moderators:
Ron Rosenes and Scott Letendre
|
8:15 am
|
Dennis
Kolson (University of Pennsylvania,
Philadelphia, PA, USA)
Brain heme
oxygenase-1 deficiency, oxidative stress
and HIV-associated neurocognitive
disorders: Potential therapeutic
targeting
|
8:45 am
|
Alan
Winston (Imperial College of London,
London, UK)
Title TBD
|
9:15 am
|
Priscilla
Hsue (University of California, San
Francisco, San Francisco, CA, USA)
HIV, inflammation,
and cardiovascular disease
|
9:45 am
|
Morning
Break (Vanity Fair Foyer)
|
Joint session 2:
Head and HAND - Biomarkers,
neuroimaging, and neuroinflammation
(Vanity Fair Ballroom, Second Level)
An in-depth
discussion of advances in
neuro-diagnostics.
Moderators:
Avindra Nath and Chris Power
|
10:00 am
|
Tricia
Burdo (Temple University, Philadelphia,
PA, USA)
Peripheral
biomarkers of HIV-associated
neurocognitive disorders
|
10:20 am
|
Bruce
Brew (University of New South Wales,
Sydney, NSW, Australia)
HAND CSF
biomarkers: Pitfalls and promises
|
10:40 am
|
Lucette
Cysique (University of New South Wales,
Sydney, NSW, Australia)
How good is MRI at
elucidating evolving HIV
neuropathogenesis? Research and clinical
implications
|
10:55 am
|
Discussion
|
Concurrent
Sessions
|
Joint session 3A:
HIV and cognitive impairment (Vanity
Fair Ballroom, Second Level)
Moderators:
Kelly Jordan-Sciutto and Brian Wigdahl
|
Joint session 3B:
HAND clinical phenotypes - Stability and
risk factors (Sovereign Ballroom, Lobby
Level)
Moderator:
Sean B. Rourke
|
11:15 am
|
Andrew
Levine (University of California, Los
Angeles, Los Angeles, CA, USA)
Peripheral blood
monocyte transcriptome at baseline
implicates Wnt-signaling pathway in
later neurocognitive change
|
11:15 am
|
Scott
Letendre (University of California, San
Diego, San Diego, CA, USA)
Neurocognitive
decline in the modern treatment era:
Measurement, correlates, and future
directions
|
11:30 am
|
Valerie
Wojna (University
of Puerto Rico, San Juan, Puerto Rico)
Insulin receptor
secretion is not associated with
abnormal glucose metabolism in
HIV-seropositive women
|
11:30 am
|
Benedetta
Milanini (University of California, San
Francisco, San Francisco, CA, USA)
HAND versus AD:
New challenge in geriatric neuroHIV
|
11:45 am
|
Seung-Wan
Yoo (Johns Hopkins University, Baltimore,
MD, USA)
Evidence that
dysfunctional endolysosomal biogenesis
is associated with cognitive impairment
in HIV-infected individuals; Agonists of
TRPML1 may restore lysosomal function
through luminal acidification
|
11:45 am
|
Lucette
Cysique (The University of New South
Wales, Sydney, Australia)
Title TBD
|
12:00 pm
|
Charles
Mactutus (University of South Carolina,
Columbia, SC, USA)
Progressive
deficits in sustained attention with
advancing age in the HIV-1 transgenic
(Tg) rat
|
12:00 pm
|
Eileen
Martin (Rush University, Chicago, IL, USA)
Sex differences in
HIV and neurocognition
|
|
|
12:15 pm
|
James
Becker (University of Pittsburgh,
Pittsburgh, PA, USA)
Title TBD
|
12:15 pm
|
Lunch
Break & Networking (talks resume at
1:45 pm)
|
Concurrent Tracks
|
ISNV Track: Viral
Pathogenesis
(Vanity Fair Ballroom, Second Level)
|
OHTN Track:
Implications of neurovirology
discoveries for clinical care (Sovereign
Ballroom, Lobby Level)
|
|
ISNV Session 1:
CNS reservoirs and HIV eradication
Moderators:
Kamel Khalili and Howard Gendelman
|
|
OHTN Session 1:
HAND diagnostic issues - Healthcare
practitioner perspectives
Why is it
important? What are the implications for
care?
Moderator:
Julian Falutz
|
1:45 pm
|
Kamel
Khalili (Temple University, Philadelphia,
PA, USA)
Update on gene
editing and eradication of HIV
|
1:45 pm
|
Jose Munoz-Moreno (Fundacio LLuita contra la SIDA,
Barcelona, Spain)
Psychology /
Neuropsychologic
|
2:00 pm
|
Paradigm Builder
Lectureship
Jonathan
Karn (Case Western Reserve University,
Cleveland, OH, USA)
Control of HIV
latency and transcription in microglial
cells
Introduction
by Kamel Khalili
|
2:00 pm
|
Reuben
Robbins (Columbia University, New York,
NY, USA)
Neuropsychologic
|
2:30 pm
|
Eric
Cohen (McGill University, Montreal,
Quebec, Canada)
Are macrophages a
reservoir of HIV-1?
|
2:15 pm
|
Adriana
Carvalhal (St. Michael's Hospital,
Toronto, Ontario, Canada)
Psychiatric
|
2:50 pm
|
Howard
Gendelman (University of Nebraska Medical
Center, Omaha, NE, USA)
Development of
long-acting reservoir targeted anti-HIV
slow release compounds for viral
eradication
|
2:30 pm
|
Lesley
Fellows (McGill University, Montreal,
Quebec, Canada)
Neurological
|
|
|
2:45 pm
|
Discussion
|
3:15 pm
|
Afternoon
Break (Vanity Fair Foyer, Second Level)
|
|
ISNV Session 2:
Extracellular vesicles in HIV
neuropathogenesis
Moderators:
Shilpa Buch and Ilker Sariyer
|
|
OHTN Session 2:
Strategies to manage neurocognitive
impairments
An overview of
biomedical, clinical, and other
interventions to help people with HIV
delay or manage neurological issues
Moderator:
John Gill
|
3:30 pm
|
Fatah
Kashanchi (George Mason University,
Manassas, VA, USA)
Exosomes from
donor and recipient cells: Role of
exosomes in HIV latency in cART treated
cells
|
3:30 pm
|
Ned
Sacktor (Johns Hopkins University,
Baltimore, MD, USA)
Clinical
management of HIV associated
neurocognitive disorders
|
4:00 pm
|
Michal
Toborek (University of Miami, Miami, FL,
USA)
Extracellular
vesicles are amyloid carriers in
HIV-infected brains
|
3:50 pm
|
David
Moore (University of California, San
Diego, San Diego, CA, USA)
Exercise
interventions
|
4:45 pm
|
Tribute to Dr.
Donald Gilden (Windsor Ballroom, Lower
Level)
|
4:10 pm
|
David
Vance (University of Alabama at
Birmingham, Birmingham, AL, USA)
Brain fitness
interventions
|
6:30 pm
|
Junior
Scientists/Women in NeuroVirology Event
(Windsor Ballroom,
Lower Level)
|
4:30 pm
|
Jose Munoz-Moreno (Fundacio LLuita contra la SIDA,
Barcelona, Spain)
Psychological /
CBT interventions
|
|
|
|
OHTN Session 3:
HIV and brain in 90 minutes - Key
implications of new research for
clinical practice
Highlights of key
findings. The 10 things you need to know
in practice. Talk to the researchers. A
special session for clinicians who were
not able to attend the full conference.
Moderator:
John Gill
|
|
|
5:00 pm
|
Brief
presentations
|
|
|
5:30 pm
|
Panel
discussion
Panelists:
Bruce Brew, Lucette Cysique, Jose
Munoz-Moreno, Reuben Robbins, David Moore,
David Vance, Ned Sacktor, Lesley Fellows,
Scott Letendre, Adriana Carvalhal, Eileen
Martin, James Becker, Julian Falutz,
Victor Valcour, Chris Power
|
|
|
6:30 pm
|
OHTN Reception and
Poster Session
|
|